Test filters

Statements

8 May 2025

DNDi’s briefing note for 78^th World Health Assembly

News

30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Scientific articles

29 Apr 2025

Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study

The Lancet Global Health

Scientific articles

29 Apr 2025

Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study

The Lancet Global Health

In the media

28 Apr 2025

World’s only research centre for flesh-eating infection ransacked in Sudan

The Telegraph

In the media

25 Apr 2025

UK city leads fight against one of Africa, Asia and Brazil’s deadliest parasites

Express

In the media

25 Apr 2025

Uni study trials new treatment for deadly disease

BBC

News

25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

In the media

24 Apr 2025

Sudan war destroys world’s only research centre on skin disease mycetoma: director

France 24

Press releases

24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

In the media

23 Apr 2025

Race against time: New treatment for deadly HIV complication enters trials

Daily Nation

Press releases

23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Scientific articles

21 Apr 2025

A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center

PLOS Neglected Tropical Diseases

Scientific articles

17 Apr 2025

Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network

The Lancet Child & Adolescent Health

In the media

17 Apr 2025

New treatment for deadly HIV-linked meningitis enters phase II trial

The Standard

In the media

17 Apr 2025

Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai

RTS

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

DNDi’s briefing note for 78^th World Health Assembly

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study

Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study

World’s only research centre for flesh-eating infection ransacked in Sudan

UK city leads fight against one of Africa, Asia and Brazil’s deadliest parasites

Uni study trials new treatment for deadly disease

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Sudan war destroys world’s only research centre on skin disease mycetoma: director

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Race against time: New treatment for deadly HIV complication enters trials

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center

Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network

New treatment for deadly HIV-linked meningitis enters phase II trial

Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai

Learn more

Get in touch

Support us

Work with us